Literature DB >> 31164428

Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis.

Joseph Barnett1, Philip L Molyneaux2, Bhavin Rawal3, Rezaur Abdullah4, Samanjit S Hare5, Rama Vancheeswaran4, Sujal R Desai3, Toby M Maher2, Athol U Wells6, Anand Devaraj3,2.   

Abstract

BACKGROUND: Mosaic attenuation on computed tomography (CT) has been identified in international guidelines as an important diagnostic feature of fibrotic hypersensitivity pneumonitis (FHP) as opposed to idiopathic pulmonary fibrosis (IPF). However, mosaic attenuation comprises several different radiological signs (low-density lobules, preserved lobules, air trapping and the so-called "headcheese sign") which may have differing diagnostic utility. Furthermore, the extent of mosaic attenuation required to distinguish these two diagnoses is uncertain and thresholds of mosaic attenuation from international guidelines have not been validated.
METHODS: Inspiratory and expiratory CT scans were evaluated by two readers in 102 patients (IPF n=57; FHP n=45) using a semiquantitative scoring system for mosaic attenuation. Findings were validated in an external cohort from a secondary referral institution (IPF n=34; FHP n=28).
RESULTS: Low-density lobules and air trapping were a frequent finding in IPF, present in up to 51% of patients. A requirement for increasing extent of low-density lobules and air trapping based on guidelines (American Thoracic Society and Fleischner Society) was associated with increased specificity for the diagnosis of FHP (0.96 and 0.98, respectively) but reduced sensitivity (0.16 and 0.20, respectively). The headcheese sign was found to be highly specific (0.93) and moderately sensitive (0.49) for a high-confidence diagnosis of FHP. The high specificity of the headcheese sign was maintained in the validation cohort and when patients with other CT features of FHP were excluded.
CONCLUSION: Mosaic attenuation is a frequent finding in IPF. However, the headcheese sign can be confidently considered as being inconsistent with a diagnosis of IPF and specific for FHP.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 31164428     DOI: 10.1183/13993003.00531-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  High-resolution computed tomography features of asbestosis versus fibrotic hypersensitivity pneumonitis: an observational study.

Authors:  Ruimin Ma; Shuang Li; Yuanying Wang; Shuqiao Yang; Na Bao; Qiao Ye
Journal:  BMC Pulm Med       Date:  2022-05-25       Impact factor: 3.320

2.  Mosaic attenuation in non-fibrotic areas as a predictor of non-usual interstitial pneumonia pathologic diagnosis.

Authors:  Ignacio Gayá García-Manso; Juan Arenas-Jiménez; Raquel García-Sevila; Sandra Ruiz-Alcaraz; Marina Sirera-Matilla; Elena García-Garrigós; María Ángeles Martínez-García; Luis Hernández-Blasco
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

3.  The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: "hexagonal pattern": a single-center retrospective study.

Authors:  Hiroko Okabayashi; Taiki Fukuda; Tae Iwasawa; Tsuneyuki Oda; Hideya Kitamura; Tomohisa Baba; Tamiko Takemura; Takuro Sakagami; Takashi Ogura
Journal:  BMC Pulm Med       Date:  2022-03-04       Impact factor: 3.317

Review 4.  [Diagnosis of Hypersensitivity Pneumonitis: 2020 Clinical Practice Guideline].

Authors:  Soojung Park; Yu-Whan Oh; Eun-Young Kang; Hwan Seok Yong; Cherry Kim; Ki Yeol Lee; Sung Ho Hwang
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-07-26

5.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

6.  Clinical diagnosis of patients subjected to surgical lung biopsy with a probable usual interstitial pneumonia pattern on high-resolution computed tomography.

Authors:  Regina Celia Carlos Tibana; Maria Raquel Soares; Karin Mueller Storrer; Gustavo de Souza Portes Meirelles; Katia Hidemi Nishiyama; Israel Missrie; Ester Nei Aparecida Martins Coletta; Rimarcs Gomes Ferreira; Carlos Alberto de Castro Pereira
Journal:  BMC Pulm Med       Date:  2020-11-16       Impact factor: 3.317

Review 7.  Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches.

Authors:  Teng Moua; Tananchai Petnak; Antonios Charokopos; Misbah Baqir; Jay H Ryu
Journal:  J Clin Med       Date:  2022-03-08       Impact factor: 4.241

Review 8.  A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease.

Authors:  Christopher J Ryerson; Tamera J Corte; Jeffrey L Myers; Simon L F Walsh; Sabina A Guler
Journal:  Eur Respir J       Date:  2021-12-16       Impact factor: 16.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.